209 related articles for article (PubMed ID: 27706226)
21. Progestins and breast cancer.
Pasqualini JR; Paris J; Sitruk-Ware R; Chetrite G; Botella J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):225-35. PubMed ID: 9699877
[TBL] [Abstract][Full Text] [Related]
22. Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate.
Xie BC; Song SY; Xie XY; Sun YT; Zhang XY; Xu DH; Huang YS
Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800295. PubMed ID: 30600539
[TBL] [Abstract][Full Text] [Related]
23. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord.
Saredi S; Patte-Mensah C; Melcangi RC; Mensah-Nyagan AG
Neuroscience; 2005; 135(3):869-77. PubMed ID: 16111823
[TBL] [Abstract][Full Text] [Related]
24. Nomegestrol acetate, a novel progestogen for oral contraception.
Mueck AO; Sitruk-Ware R
Steroids; 2011 May; 76(6):531-9. PubMed ID: 21335021
[TBL] [Abstract][Full Text] [Related]
25. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
26. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
Mansour D; Westhoff C; Kher U; Korver T
Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
[TBL] [Abstract][Full Text] [Related]
27. [Nomegestrol acetate: clinical pharmacology].
Lello S
Minerva Ginecol; 2009 Oct; 61(5):459-63. PubMed ID: 19749678
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Africander DJ; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of murine type VI 3β-hydroxysteroid dehydrogenase in the adrenal gland, testis, skin, and placenta.
Yamamura K; Doi M; Hayashi H; Ota T; Murai I; Hotta Y; Komatsu R; Okamura H
Mol Cell Endocrinol; 2014 Jan; 382(1):131-138. PubMed ID: 24075909
[TBL] [Abstract][Full Text] [Related]
30. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Ma AY; Xie SW; Zhou JY; Zhu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
[TBL] [Abstract][Full Text] [Related]
31. Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate.
Simoncini T; Caruso A; Garibaldi S; Fu XD; Giretti MS; Baldacci C; Scorticati C; Fornari L; Mannella P; Genazzani AR
Obstet Gynecol; 2006 Oct; 108(4):969-78. PubMed ID: 17012461
[TBL] [Abstract][Full Text] [Related]
32. Biological effects of progestins in breast cancer.
Pasqualini JR; Ebert C; Chetrite GS
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():44-52. PubMed ID: 12227886
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the central effects of different progestins used in hormone replacement therapy.
Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
[TBL] [Abstract][Full Text] [Related]
34. The "newer" progestogens and postmenopausal hormone therapy (HRT).
Schindler AE
J Steroid Biochem Mol Biol; 2014 Jul; 142():48-51. PubMed ID: 24333799
[TBL] [Abstract][Full Text] [Related]
35. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women.
Cagnacci A; De Toni A; Caretto S; Menozzi R; Bondi M; Corradini B; Alessandrini C; Volpe A
Menopause; 2006; 13(2):197-201. PubMed ID: 16645533
[TBL] [Abstract][Full Text] [Related]
36. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
Sitruk-Ware R
Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
[TBL] [Abstract][Full Text] [Related]
37. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
[TBL] [Abstract][Full Text] [Related]
38. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
39. Steroids and endocrine disruptors--History, recent state of art and open questions.
Hampl R; Kubátová J; Stárka L
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):217-23. PubMed ID: 24816231
[TBL] [Abstract][Full Text] [Related]
40. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
